Exapto

The chemical industry is responsible for 5.8% of global CO₂ emissions and is heavily reliant on fossil fuels, both as a feedstock and as an energy source. This dependence not only contributes significantly to climate change but also exposes the industry to high price volatility and increasing regulatory pressure. While bio-based alternatives have long been seen as a solution, they’ve struggled to scale due to low yields, unpredictable development timelines, and uncompetitive production costs. As a result, bio-manufacturing has remained limited to niche or subsidised markets, leaving the majority of the sector reliant on unsustainable processes.

Exapto leverages more than a decade of research in metabolic engineering and synthetic biology to reprogramme microorganisms into efficient, scalable bio-factories. Their platform enables the production of key chemical building blocks through sustainable fermentation processes, offering industrial clients ready-to-use strains and step-by-step production protocols. This drastically reduces the carbon footprint associated with traditional chemical synthesis, lowers dependency on petrochemical inputs, and helps accelerate the industry’s transition to green chemistry across sectors like cosmetics, plastics, and advanced materials.

We measure the amount of CO₂ emissions avoided by replacing fossil-based chemical production with Exapto’s bio-based alternatives, the number of industrial-scale fermentation processes launched using Exapto strains, and yield improvements (g/L) compared to conventional bio-production methods, reflecting enhanced competitiveness and scalability.